glp-1 oral health news OH NO OZEMPIC: How RAs May Be Slimming Down Your There’s a new oral GLP-1

Regardless of the mechanism, the outcome can feel similar: progress slows or stops

September 30, 2025

Uncontrolled blood sugar

Fortunately, GLP1 medications are now FDA-indicated for multiple indications beyond weight management and diabetes, including: Major cardiovascular event (heart attack and/or stroke) risk reduction in adults with cardiovascular disease and overweight or obesity Metabolic dysfunctionassociated steatohepatitis (MASH) Moderate to severe obstructive sleep apnea (OSA) in adults with obesity When one medication can address multiple conditions, it simplifies care and reduces polypharmacy

The 2016 James D

Whats the technology behind the VOL.U.LIFT innovation